Alumis (ALMS) Prepaid Assets (2024 - 2025)
Alumis (ALMS) posted quarterly Prepaid Assets of $3.9 million for Q1 2025, up 414.17% quarter-over-quarter from $762000.0 in Q4 2024.
Alumis (ALMS) Prepaid Assets (2024 - 2025) Analysis & Trends
Alumis (ALMS) has reported Prepaid Assets for 2 consecutive years, with $3.9 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Prepaid Assets changed N/A year-over-year to $3.9 million; the TTM figure through Mar 2025 stood at $3.9 million (changed N/A YoY), while the FY2024 annual figure was $762000.0, changed N/A from the prior year.
- Prepaid Assets climbed to $3.9 million in Q1 2025 per ALMS's latest filing, from $762000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.9 million in Q1 2025 and bottomed at $762000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alumis | 3.25 Bn | 2.75 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.92 Mn |
| Dec 31, 2024 | 762,000.00 |